|
1
|
Sbaraglia M, Righi A, Gambarotti M and Dei Tos AP: Ewing sarcoma and Ewing-like tumors. Virchows Archiv. 476:109–119. 2020. View Article : Google Scholar
|
|
2
|
Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P and Delattre O: Mesenchymal stem cell features of Ewing tumors. Cancer Cell. 11:421–429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Riggi N, Suvà ML, Suvà D, Cironi L, Provero P, Tercier S, Joseph JM, Stehle JC, Baumer K, Kindler V, et al: EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 68:2176–2185. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
von Levetzow C, Jiang X, Gwye Y, von Levetzow G, Hung L, Cooper A, Hsu JHR and Lawlor ER: Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One. 6:e193052011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG and Scully SP: Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: An analysis of 1631 cases from the SEER database, 1973-2005. Cancer. 115:3526–3536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orr WS, Denbo JW, Billups CA, Wu J, Navid F, Rao BN, Davidoff AM and Krasin MJ: Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: Review of St. Jude Children's research hospital experience. Ann Surg Oncol. 19:3816–3822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovar H, Sorensen PH, Delattre O and Dirksen U: Ewing sarcoma. Nat Rev Dis Primers. 4:52018. View Article : Google Scholar
|
|
8
|
Sand LGL, Szuhai K and Hogendoorn PCW: Sequencing over- view of Ewing sarcoma: A journey across genomic, epigenomic and transcriptomic landscapes. Int J Mol Sci. 16:16176–16215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suvà ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, Suvà D, Clément V, Provero P, Cironi L, et al: Identification of cancer stem cells in Ewing's sarcoma. Cancer Res. 69:1776–1781. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang M, Zhang R, Yan M, Ye Z, Liang W and Luo Z: Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro. Biochem Biophys Res Commun. 391:1062–1066. 2010. View Article : Google Scholar
|
|
11
|
Helman LJ and Meltzer P: Mechanisms of sarcoma development. Nat Rev Cancer. 3:685–694. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hotfilder M, Mallela N, Seggewiß J, Dirksen U and Korsching E: Defining a characteristic gene expression set responsible for cancer stem cell-like features in a sub-population of ewing sarcoma cells CADO-ES1. Int J Mol Sci. 19:39082018. View Article : Google Scholar
|
|
13
|
Tanabe A and Sahara H: The metabolic heterogeneity and flexibility of cancer stem cells. Cancers (Basel). 12:27802020. View Article : Google Scholar
|
|
14
|
Park E, Pan Z, Zhang Z, Lin L and Xing Y: The expanding landscape of alternative splicing variation in human populations. Am J Hum Genet. 102:11–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu B, Meng Y and Jin Y: RNA structures in alternative splicing and back-splicing. Wiley Interdiscip Rev RNA. 12. pp. e16262021, View Article : Google Scholar
|
|
16
|
Oltean S and Bates DO: Hallmarks of alternative splicing in cancer. Oncogene. 33:5311–5318. 2014. View Article : Google Scholar
|
|
17
|
Patócs B, Németh K, Garami M, Arató G, Kovalszky I, Szendrői M and Fekete G: Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors. Cell Oncol (Dordr). 36:191–200. 2013. View Article : Google Scholar
|
|
18
|
Sand LGL, Jochemsen AG, Beletkaia E, Schmidt T, Hogendoorn PCW and Szuhai K: Novel splice variants of CXCR4 identified by transcriptome sequencing. Biochem Biophys Res Commun. 466:89–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Selvanathan SP, Graham GT, Grego AR, Baker TM, Hogg JR, Simpson M, Batish M, Crompton B, Stegmaier K, Tomazou EM, et al: EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex. Nucleic Acids Res. 47:9619–9636. 2019.PubMed/NCBI
|
|
20
|
Bartys N, Kierzek R and Lisowiec-Wachnicka J: The regulation properties of RNA secondary structure in alternative splicing. Biochim Biophys Acta Gene Regul Mech. 1862:1944012019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, Zhou Q and Xing Y: rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA. 111:E5593–E5601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding L, Rath E and Bai Y: Comparison of alternative splicing junction detection tools using RNA-Seq data. Curr Genomics. 18:268–277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mehmood A, Laiho A, Venäläinen MS, McGlinchey AJ, Wang N and Elo LL: Systematic evaluation of differential splicing tools for RNA-seq studies. Brief Bioinform. 21:2052–2065. 2020. View Article : Google Scholar :
|
|
24
|
Kodama K, Doi O, Higashiyama M, Mori Y, Horai T, Tateishi R, Aoki Y and Misawa S: Establishment and characterization of a new Ewing's sarcoma cell line. Cancer Genet Cytogenet. 57:19–30. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leuchte K, Altvater B, Hoffschlag S, Potratz J, Meltzer J, Clemens D, Luecke A, Hardes J, Dirksen U, Juergens H, et al: Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function. Oncol Rep. 32:845–852. 2014. View Article : Google Scholar
|
|
26
|
Amaral AT, Manara MC, Berghuis D, Ordóñez JL, Biscuola M, Lopez-García MA, Osuna D, Lucarelli E, Alviano F, Lankester A, et al: Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications. PLoS One. 9:e858142014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Unland R, Clemens D, Heinicke U, Potratz JC, Hotfilder M, Fulda S, Wardelmann E, Frühwald MC and Dirksen U: Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines. Anticancer Drugs. 26:843–851. 2015. View Article : Google Scholar
|
|
28
|
Kailayangiri S, Altvater B, Lesch S, Balbach S, Göttlich C, Kühnemundt J, Mikesch JH, Schelhaas S, Jamitzky S, Meltzer J, et al: EZH2 inhibition in Ewing sarcoma upregulates G D2 expression for targeting with gene-modified T cells. Mol Ther. 27:933–946. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Villegas J and McPhaul M: Establishment and culture of human skin fibroblasts. Curr Protoc Mol Biol. 28:Unit 28.3. 2005.
|
|
30
|
Schmid F, Glaus E, Barthelmes D, Fliegauf M, Gaspar H, Nürnberg G, Nürnberg P, Omran H, Berger W and Neidhardt J: U1 snRNA-mediated gene therapeutic correction of splice defects caused by an exceptionally mild BBS mutation. Hum Mutat. 32:815–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haas BJ, Dobin A, Li B, Stransky N, Pochet N and Regev A: Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20:2132019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Knoop LL and Baker SJ: The splicing factor U1C represses EWS/FLI-mediated transactivation. J Biol Chem. 275:24865–24871. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen S, Park JW, Huang J, Dittmar KA, Lu Zx, Zhou Q, Carstens RP and Xing Y: MATS: A Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data. Nucleic Acids Res. 40:e612012. View Article : Google Scholar :
|
|
34
|
Bürger H, de Boer M, van Diest PJ and Korsching E: Chromosome 16q loss-a genetic key to the understanding of breast carcinogenesis. Histol Histopathol. 28:311–320. 2013.
|
|
35
|
Sánchez L, Gutierrez-Aranda I, Ligero G, Rubio R, Muñoz-López M, García-Pérez JL, Ramos V, Real PJ, Bueno C, Rodríguez R, et al: Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells. 29:251–262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, McGee-Lawrence ME, Decker M and Westendorf JJ: The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation. J Cell Biochem. 111:933–943. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kubo H, Shimizu M, Taya Y, Kawamoto T, Michida M, Kaneko E, Igarashi A, Nishimura M, Segoshi K, Shimazu Y, et al: Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry. Genes Cells. 14:407–424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pelekanos RA, Li J, Gongora M, Chandrakanthan V, Scown J, Suhaimi N, Brooke G, Christensen ME, Doan T, Rice AM, et al: Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res. 8:58–73. 2012. View Article : Google Scholar
|
|
39
|
Chen M, Xiao J, Zhang Z, Liu J, Wu J and Yu J: Identification of human HK genes and gene expression regulation study in cancer from transcriptomics data analysis. PLoS One. 8:e540822013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rau A, Gallopin M, Celeux G and Jaffrézic F: Data-based filtering for replicated high-throughput transcriptome sequencing experiments. Bioinformatics. 29:2146–2152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, Szczesniak MW, Gaffney DJ, Elo LL, Zhang X and Mortazavi A: A survey of best practices for RNA-seq data analysis. Genome Biol. 17:132016. View Article : Google Scholar :
|
|
42
|
Shen M, Haggblom C, Vogt M, Hunter T and Lu KP: Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis. Proc Natl Acad Sci USA. 94:13618–13623. 1997. View Article : Google Scholar
|
|
43
|
Ogawa F, Malavasi EL, Crummie DK, Eykelenboom JE, Soares DC, Mackie S, Porteous DJ and Millar JK: DISC1 complexes with TRAK1 and miro1 to modulate anterograde axonal mitochondrial trafficking. Hum Mol Genet. 23:906–919. 2014. View Article : Google Scholar :
|
|
44
|
Sbodio JI and Chi NW: Identification of a tankyrase-binding motif shared by IRAP, TAB182, and human TRF1 but not mouse TRF1. NuMA contains this RXXPDG motif and is a novel tankyrase partner. J Biol Chem. 277:31887–31892. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kraft C, Vodermaier HC, Maurer-Stroh S, Eisenhaber F and Peters JM: The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol Cell. 18:543–553. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Costessi A, Mahrour N, Sharma V, Stunnenberg R, Stoel MA, Tijchon E, Conaway JW, Conaway RC and Stunnenberg HG: The human EKC/KEOPS complex is recruited to Cullin2 ubiquitin ligases by the human tumour antigen PRAME. PLoS One. 7:e428222012. View Article : Google Scholar :
|
|
47
|
Braun DA, Rao J, Mollet G, Schapiro D, Daugeron MC, Tan W, Gribouval O, Boyer O, Revy P, Jobst-Schwan T, et al: Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nat Genet. 49:1529–1538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu D, Safari A, O'Connor MS, Chan DW, Laegeler A, Qin J and Songyang Z: PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol. 6:673–680. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Y, LeRoy G, Seelig HP, Lane WS and Reinberg D: The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell. 95:279–289. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kuzmichev A, Zhang Y, Erdjument-Bromage H, Tempst P and Reinberg D: Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33 (ING1). Mol Cell Biol. 22:835–848. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fang W, Goldberg ML, Pohl NM, Bi X, Tong C, Xiong B, Koh TJ, Diamond AM and Yang W: Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. Carcinogenesis. 31:1360–1366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fu J, Qin L, He T, Qin J, Hong J, Wong J, Liao L and Xu J: The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res. 21:275–289. 2011. View Article : Google Scholar
|
|
53
|
Nakao A, Yoshihama M and Kenmochi N: RPG: The ribosomal protein gene database. Nucleic Acids Res. 32(Database issue): D168–D170. 2004. View Article : Google Scholar :
|
|
54
|
Zeqiraj E, Filippi BM, Deak M, Alessi DR and van Aalten DM: Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science. 326:1707–1711. 2009. View Article : Google Scholar
|
|
55
|
Inoue D, Fujino T, Sheridan P, Zhang YZ, Nagase R, Horikawa S, Li Z, Matsui H, Kanai A, Saika M, et al: A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies. Leukemia. 32:1327–1337. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Macaluso M, Cinti C, Russo G, Russo A and Giordano A: p R b2 / p13 0 - E 2 F 4 /5 - H DAC1- S U V39 H1- p3 00 an d pRb2/p130-E2F4/5HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene. 22:3511–3517. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Xue Y, Canman JC, Lee CS, Nie Z, Yang D, Moreno GT, Young MK, Salmon ED and Wang W: The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci USA. 97:13015–13020. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R, Gordon C, Naumann M and Dubiel W: A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J. 12:469–478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Groisman R, Polanowska J, Kuraoka I, Sawada Ji, Saijo M, Drapkin R, Kisselev AF, Tanaka K and Nakatani Y: The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell. 113:357–367. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Iyer SP, Akimoto Y and Hart GW: Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J Biol Chem. 278:5399–5409. 2003. View Article : Google Scholar
|
|
61
|
van Nuland R, Smits AH, Pallaki P, Jansen PW, Vermeulen M and Timmers HT: Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Mol Cell Biol. 33:2067–2077. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ding X, Jiang W, Zhou P, Liu L, Wan X, Yuan X, Wang X, Chen M, Chen J, Yang J, et al: Mixed lineage leukemia 5 (MLL5) protein stability is cooperatively regulated by O-GlcNac transferase (OGT) and ubiquitin specific protease 7 (USP7). PLoS One. 10:e01450232015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, Parsons R, Zhao K and Wang W: PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev. 19:1662–1667. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Holaska JM and Wilson KL: An emerin 'proteome': Purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture. Biochemistry. 46:8897–8908. 2007. View Article : Google Scholar
|
|
65
|
Battle A, Mostafavi S, Zhu X, Potash JB, Weissman MM, McCormick C, Haudenschild CD, Beckman KB, Shi J, Mei R, et al: Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 24:14–24. 2014. View Article : Google Scholar :
|
|
66
|
Consortium G. Human genomics: The genotype-tissue expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 348:648–660. 2015. View Article : Google Scholar
|
|
67
|
Pala M, Zappala Z, Marongiu M, Li X, Davis JR, Cusano R, Crobu F, Kukurba KR, Gloudemans MJ, Reinier F, et al: Population- and individual-specific regulatory variation in Sardinia. Nat Genet. 49:700–707. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sammeth M, Foissac S and Guigó R: A general definition and nomenclature for alternative splicing events. PLoS Comput Biol. 4:e10001472008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lau E, Han Y, Williams DR, Thomas CT, Shrestha R, Wu JC and Lam MPY: Splice-junction-based mapping of alternative isoforms in the human proteome. Cell Rep. 29:3751–3765.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Monteuuis G, Wong JJL, Bailey CG, Schmitz U and Rasko JEJ: The changing paradigm of intron retention: Regulation, ramifications and recipes. Nucleic Acids Res. 47:11497–11513. 2019.PubMed/NCBI
|
|
71
|
Tress ML, Abascal F and Valencia A: Alternative splicing may not be the key to proteome complexity. Trends Biochem Sci. 42:98–110. 2017. View Article : Google Scholar
|
|
72
|
Blencowe BJ: The relationship between alternative splicing and proteomic complexity. Trends Biochem Sci. 42:407–408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Huang H, Tong TT, Yau LF, Wang JR, Lai MH, Zhang CR, Wen XH, Li SN, Li KY, Liu JQ, et al: Chemerin isoform analysis in human biofluids using an LC/MRM-MS-based targeted proteomics approach with stable isotope-labeled standard. Anal Chim Acta. 1139:79–87. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Hamouda NN, Van den Haute C, Vanhoutte R, Sannerud R, Azfar M, Mayer R, Calabuig ÁC, Swinnen JV, Agostinis P, Baekelandt V, et al: ATP13A3 is a major component of the enigmatic mammalian polyamine transport system. J Biol Chem. 296:1001822021. View Article : Google Scholar :
|
|
75
|
Yuan J, Xing H, Li Y, Song Y, Zhang N, Xie M, Liu J, Xu Y, Shen Y, Wang B, et al: EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC. Cancer Lett. 499:255–264. 2021. View Article : Google Scholar
|
|
76
|
Zhao X, Qin W, Jiang Y, Yang Z, Yuan B, Dai R, Shen H, Chen Y, Fu J and Wang H: ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma. NPJ Precis Oncol. 4:72020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Yu G, Zhao Y and Li H: The multistructural forms of box C/D ribonucleoprotein particles. RNA. 24:1625–1633. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yang YG, Sari IN, Zia MF, Lee SR, Song SJ and Kwon HY: Tetraspanins: Spanning from solid tumors to hematologic malignancies. Exp Hematol. 44:322–328. 2016. View Article : Google Scholar
|
|
79
|
Zhang Y, Qian J, Gu C and Yang Y: Alternative splicing and cancer: A systematic review. Signal Transduct Target Ther. 6:782021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Selvanathan SP, Graham GT, Erkizan HV, Dirksen U, Natarajan TG, Dakic A, Yu S, Liu X, Paulsen MT, Ljungman ME, et al: Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proc Natl Acad Sci USA. 112:E1307–E1316. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Boulay G, Sandoval GJ, Riggi N, Iyer S, Buisson R, Naigles B, Awad ME, Rengarajan S, Volorio A, McBride MJ, et al: Cancer-specific retargeting of BAF complexes by a prion-like domain. Cell. 171:163–178.e19. 2017. View Article : Google Scholar
|
|
82
|
Spahn L, Siligan C, Bachmaier R, Schmid JA, Aryee DNT and Kovar H: Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein. Oncogene. 22:6819–6829. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lee MJ and Yaffe MB: Protein regulation in signal transduction. Cold Spring Harb Perspect Biol. 8:a0059182016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Dvinge H: Regulation of alternative mRNA splicing: Old players and new perspectives. FEBS Lett. 592:2987–3006. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Knoop LL and Baker SJ: EWS/FLI alters 5′-splice site selection. J Biol Chem. 276:22317–22322. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D and Dutertre M: Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer. Proc Natl Acad Sci USA. 105:6004–6009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhu X, Lan B, Yi X, He C, Dang L, Zhou X, Lu Y, Sun Y, Liu Z, Bai X, et al: HRP2-DPF3a-BAF complex coordinates histone modification and chromatin remodeling to regulate myogenic gene transcription. Nucleic Acids Res. 48:6563–6582. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Nguyen H, Sokpor G, Pham L, Rosenbusch J, Stoykova A, Staiger JF and Tuoc T: Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development. Cell Cycle. 15:1317–1324. 2016. View Article : Google Scholar :
|
|
89
|
Nguyen H, Kerimoglu C, Pirouz M, Pham L, Kiszka KA, Sokpor G, Sakib MS, Rosenbusch J, Teichmann U, Seong RH, et al: Epigenetic regulation by BAF complexes limits neural stem cell proliferation by suppressing wnt signaling in late embryonic development. Stem Cell Reports. 10:1734–1750. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Grote P and Herrmann BG: The long non-coding RNAFendrrlinks epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol. 10:1579–1585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Innis SM and Cabot B: GBAF, a small BAF sub-complex with big implications: A systematic review. Epigenetics Chromatin. 13:482020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Sveen A, Kilpinen S, Ruusulehto A, Lothe RA and Skotheim RI: Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. 35:2413–2427. 2016. View Article : Google Scholar
|
|
93
|
El Marabti E and Younis I: The cancer spliceome: Reprograming of alternative splicing in cancer. Front Mol Biosci. 5:802018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE and Triche TJ: EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res. 65:4633–4644. 2005. View Article : Google Scholar : PubMed/NCBI
|
